Literature DB >> 15618122

Dietary whey protein modulates liver glycogen level and glycoregulatory enzyme activities in exercise-trained rats.

Masashi Morifuji1, Kensuke Sakai, Katsumi Sugiura.   

Abstract

This study compared the effects of dietary whey protein with dietary casein or soy protein on glycogen storage and glycoregulatory enzyme activities in the liver of sedentary and exercise-trained rats. Male Sprague-Dawley rats (ca. 130 g) were divided into one sedentary and three exercise-trained groups, with eight animals in each group. Casein was provided as the source of dietary protein in the sedentary group while the exercise-trained groups were fed casein, whey, or soy protein. Rats in the exercise-trained groups ran for 30 mins/day, 4 days/week on a motor-driven treadmill. In the exercise-trained rats, animals fed whey protein had higher liver glycogen content than animals in the other two diet groups. Glucokinase activity was significantly higher in rats fed whey protein compared to that in rats fed soy protein, while glucose 6-phosphatase activity was significantly decreased in animals on the whey protein diet compared with those the other two diets. Although 6-phospho-fructokinase activity was significantly lower in the whey protein group than in the soy protein group, we found that fructose 1,6-bisphosphatase activity was significantly higher in the whey group compared with either the casein or soy groups. Pyruvate kinase activity in rats fed the casein diet was significantly higher than in rats fed either the whey or soy protein diets. In addition, hepatic alanine aminotransferase activity and serum alanine level were also increased in the whey protein group compared with the casein or soy protein groups. Taken together, these results demonstrate that the whey protein diet in exercise-trained rats results in significantly higher levels of liver glycogen, because of the combined effects of regulation of rate limiting glycolytic and gluconeogenic enzyme activities and activation of glycogenesis from alanine via alanine amino-transferase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618122     DOI: 10.1177/153537020523000103

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  6 in total

1.  Exercise x BCAA Supplementation in Young Trained Rats: What are their Effects on Body Growth?

Authors:  Patricia Lopes de Campos-Ferraz; Sandra Maria Lima Ribeiro; Silmara Dos Santos Luz; Antonio Herbert Lancha; Julio Tirapegui
Journal:  J Sports Sci Med       Date:  2011-09-01       Impact factor: 2.988

Review 2.  Nutrition of the critically ill - emphasis on liver and pancreas.

Authors:  Stig Bengmark
Journal:  Hepatobiliary Surg Nutr       Date:  2012-12       Impact factor: 7.293

3.  Chronic inhibition of dipeptidyl peptidase-IV with ASP8497 improved the HbA(1c) level, glucose intolerance, and lipid parameter level in streptozotocin-nicotinamide-induced diabetic mice.

Authors:  Akiko Matsuyama-Yokono; Atsuo Tahara; Ryosuke Nakano; Yuka Someya; Masahiko Hayakawa; Masayuki Shibasaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-09-02       Impact factor: 3.000

4.  Regulation of glucose homeostasis and lipid metabolism by PPP1R3G-mediated hepatic glycogenesis.

Authors:  Yongxian Zhang; Daqian Xu; Heng Huang; Susie Chen; Lingdi Wang; Lu Zhu; Xiaomeng Jiang; Xiangbo Ruan; Xiaolin Luo; Peijuan Cao; Weizhong Liu; Yi Pan; Zhenzhen Wang; Yan Chen
Journal:  Mol Endocrinol       Date:  2013-01-01

Review 5.  Nutrition of the critically ill — a 21st-century perspective.

Authors:  Stig Bengmark
Journal:  Nutrients       Date:  2013-01-14       Impact factor: 5.717

6.  The Effect of Dietary Replacement of Fish Meal with Whey Protein Concentrate on the Growth Performance, Fish Health, and Immune Status of Nile Tilapia Fingerlings, Oreochromis niloticus.

Authors:  Shimaa A Amer; Ali Osman; Naif A Al-Gabri; Shafika A M Elsayed; Ghada I Abd El-Rahman; Mohamed Tharwat Elabbasy; Shaimaa A A Ahmed; Rowida E Ibrahim
Journal:  Animals (Basel)       Date:  2019-11-20       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.